Perioperative medicine & outcomes
Neoadjuvant Semaglutide, Bariatric Surgery Weight Loss, and Overall Outcomes
Study context
- Population
- Patients undergoing metabolic and bariatric surgery
- Comparison
- GLP-1 receptor agonist use before metabolic and bariatric surgery
Original publication
Neoadjuvant Semaglutide, Bariatric Surgery Weight Loss, and Overall Outcomes. JAMA Surg. Published 1 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →